{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:30:18Z","timestamp":1777480218765,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.thromres.2023.03.011","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T04:37:06Z","timestamp":1680151026000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Geographic disparities in the care and outcomes in adult chronic immune thrombocytopenia"],"prefix":"10.1016","volume":"225","author":[{"given":"Erika","family":"Wall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Podstawka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery M.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Bolster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Dawn","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Rydz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0205-9722","authenticated-orcid":false,"given":"Haowei L.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.03.011_bb0005","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.03.011_bb0010","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"issue":"7","key":"10.1016\/j.thromres.2023.03.011_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28970","article-title":"Racial\/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors","volume":"68","author":"Puthenpura","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"29","key":"10.1016\/j.thromres.2023.03.011_bb0020","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1200\/JCO.2006.08.4103","article-title":"Site of oncologic specialty care for older adolescents in Utah","volume":"25","author":"Albritton","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.011_bb0025","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1158\/1055-9965.EPI-18-1384","article-title":"Disparities in mortality from noncancer causes among adolescents and young adults with cancer","volume":"28","author":"Anderson","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.thromres.2023.03.011_bb0030","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/cncr.32607","article-title":"Geographic and demographic features of neuroendocrine tumors in the United States of America: a population-based study","volume":"126","author":"Gosain","year":"2020","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.thromres.2023.03.011_bb0035","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/cncr.30139","article-title":"Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North Carolina","volume":"122","author":"Freeman","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.thromres.2023.03.011_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cancers12010157","article-title":"Socio-demographic disparities in gastric adenocarcinoma: a population-based study","volume":"12","author":"Rana","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.thromres.2023.03.011_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13696998.2019.1669329","article-title":"Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis","volume":"23","author":"Weycker","year":"2020","journal-title":"J. Med. Econ."},{"issue":"1","key":"10.1016\/j.thromres.2023.03.011_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40801-015-0009-6","article-title":"Intravenous immunoglobulin (IVIg) utilization in immune thrombocytopenia (ITP): a multi-center,retrospective review","volume":"2","author":"Hsia","year":"2015","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"10.1016\/j.thromres.2023.03.011_bb0055","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.clinthera.2020.02.020","article-title":"The cost-effectiveness of eltrombopag for the treatment of immune thrombocytopenia in the United States","volume":"42","author":"Tremblay","year":"2020","journal-title":"Clin. Ther."},{"key":"10.1016\/j.thromres.2023.03.011_bb0060","author":"Canada"},{"issue":"4","key":"10.1016\/j.thromres.2023.03.011_bb0065","doi-asserted-by":"crossref","DOI":"10.24095\/hpcdp.29.4.05","article-title":"A deprivation index for the health planning in Canada","volume":"29","author":"Pampalon","year":"2009","journal-title":"Chronic Dis.Can."},{"key":"10.1016\/j.thromres.2023.03.011_bb0070","series-title":"Statistics Canada Catalogue no. 82-003-XPE. Health Reports","article-title":"A comparison of individual and area-based socioeconomic data for monitoring social inequalities in health","volume":"20(3)","author":"Pampalon","year":"2009"},{"issue":"3","key":"10.1016\/j.thromres.2023.03.011_bb0075","first-page":"1","article-title":"Definition of rural.Rural and small town Canada analysis bulletin","volume":"3","author":"du Plessis","year":"2001","journal-title":"Stat. Can."},{"issue":"9078","key":"10.1016\/j.thromres.2023.03.011_bb0080","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(97)04143-3","article-title":"Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines","volume":"350","author":"Bolton-Maggs","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2023.03.011_bb0085","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood.2020004888","article-title":"Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences","volume":"136","author":"Kim","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.03.011_bb0090","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1182\/blood-2006-03-010405","article-title":"Immune thrombocytopenic purpura does not exhibit a disparity in prevalence between African American and White veterans","volume":"108","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2023.03.011_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/trf.15069","article-title":"Platelet transfusion practices in immune thrombocytopenia related hospitalizations","volume":"59","author":"Goel","year":"2019","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.thromres.2023.03.011_bb0100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00277-021-04449-4","article-title":"Temporal trends and outcome of splenectomy in adults with immune thrombocytopenia in the USA","volume":"100","author":"Finianos","year":"2021","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2023.03.011_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MBC.0b013e328332dbb6","article-title":"Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000\u20132002: a retrospective analysis","volume":"21","author":"Cirasino","year":"2010","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2023.03.011_bb0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jth.12813","article-title":"Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review","volume":"13","author":"Neunert","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.03.011_bb0120","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.03.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/1096-8652(200009)65:1<25::AID-AJH4>3.0.CO;2-8","article-title":"Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist","volume":"65","author":"Brigden","year":"2000","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2023.03.011_bb0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajh.23930","article-title":"Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France","volume":"90","author":"Moulis","year":"2015","journal-title":"Am. J. Hematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:50:21Z","timestamp":1758736221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":25,"alternative-id":["S0049384823000853"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.03.011","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geographic disparities in the care and outcomes in adult chronic immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}